| Section | Status | CCG | Name |
| 10.01.03 | Restricted Use | 
| Adalimumab |
| 18 | Formulary |
| Andexanet alfa Ondexxya® |
| 09.01.04 | Formulary |
| Avatrombopag Doptelet® |
| 13.05.03 | Formulary |
| Baricitinib Olumiant® |
| 04.12 | Formulary |
| Botulinum neurotoxin type A Xeomin® |
| 10.01.03 | Restricted Use |
| Brodalumab Kyntheum® |
| 11.08.02 | Formulary |
| Brolucizumab Beovu® |
| 08.03.04.02 | Formulary |
| Degarelix |
| 13.05.03 | Formulary |
| Dimethyl fumarate Skilarence® |
| 04.07.04.02 | Formulary |
| Erenumab Aimovig® |
| 10.01.03 | Formulary |
| Filgotinib Jyseleca® |
| 04.07.04.02 | Formulary |
| Fremanezumab Ajovy® |
| 04.07.04.02 | Formulary |
| Galcanezumab Emgality® |
| 10.01.03 | Restricted Use |
| Golimumab Simponi® |
| 13.05.03 | Formulary |
| Guselkumab Tremfya® |
| 13.05.03 | Formulary |
| Ixekizumab Taltz® |
| 09.01.04 | Formulary |
| Lusutrombopag Mulpleo® |
| 01.06.06 | Formulary |
| Naldemedine Rizmoic® |
| 09.02.01.01 | Formulary |
| Patiromer Veltassa® |
| 07.04.03 | Formulary |
| Pentosan polysulfate sodium Elmiron® |
| 13.05.02 | Formulary |
| Risankizumab Skyrizi |
| 03.03.03 | Formulary |
| Roflumilast Daxas® |
| 08.02.04 | Formulary |
| Sarilumab Kevzara® |
| 09.02.01.01 | Formulary |
| Sodium zirconium cyclosilicate Lokelma® |
| 13.05.03 | Formulary |
| Tildrakizumab Ilumya® |
| 10.01.03 | Formulary |
| Upadacitinib Rinvoq® |